Filter Results :

Your search for Biotech returned 368 reports

Sort by


Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Feb 2017  |  Published by:  GlobalData
SummaryActive Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed ou...

$ 250.00

Read More

Mount Tam Biotechnologies Inc (MNTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Feb 2017  |  Published by:  GlobalData
SummaryMount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a biopharmaceutical company that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog th...

$ 250.00

Read More

Milo Biotechnology LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Feb 2017  |  Published by:  GlobalData
SummaryMilo Biotechnology LLC (Milo) is a biotech company that develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The company’s pipeline product AAV1 (based on adeno-associated virus) is a gene therapy for the one time treatment option for muscle wastin...

$ 250.00

Read More

M3 Biotechnology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Feb 2017  |  Published by:  GlobalData
SummaryM3 Biotechnology Inc (M3 Biotech) is a therapeutics company with a focus on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. Its lead compound, MM-201, a therapeutic program, is an ...

$ 250.00

Read More

Biotechnology Equipment Markets in China

15 Feb 2017  |  Published by:  Asia Market Info and Dev Co.
China's demand for Biotechnology Equipment has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export...

$ 4,000.00

Read More

Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review

15 Feb 2017  |  Published by:  GlobalData
Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ...

$ 125.00

Read More

Biotechnology Equipment Industry Forecasts - China Focus

15 Feb 2017  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China's Biotechnology Equipment industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is ...

$ 1,800.00

Read More

Biotechnology Equipment Companies in China

15 Feb 2017  |  Published by:  Asia Market Info and Dev Co.
This study focuses on China's Biotechnology Equipment industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society...

$ 1,800.00

Read More

Apex Biotechnology Corp. (1733) - Medical Equipment - Deals and Alliances Profile

14 Feb 2017  |  Published by:  GlobalData
SummaryApex Biotechnology Corp. (ApexBio) is a medical device company. It develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company's products consist of patient self-testing products, point of care diagnostics and multi-functional products. The company ...

$ 250.00

Read More

Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review

08 Feb 2017  |  Published by:  GlobalData
Oncolytics Biotech Inc (ONC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknes...

$ 125.00

Read More

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2017

02 Feb 2017  |  Published by:  CurrentPartnering
The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies ...

$ 2,995.00

Read More

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010- 2017

01 Feb 2017  |  Published by:  CurrentPartnering
Essential Benchmark Data for Dealmakers - The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2017 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone pa...

$ 2,995.00

Read More

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies "The Global Co-development ...

$ 2,995.00

Read More

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare comp...

$ 2,995.00

Read More

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies "The Global Royalty Fi...

$ 1,995.00

Read More
Total 368 records.